ARMATA PHARMACEUTICALS, INC. Secured Long-term Debt, Noncurrent
ARMATA PHARMACEUTICALS, INC. (ARMP) had Secured Long-term Debt, Noncurrent of $42.02 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:SecuredLongTermDebt · last filed 2026-08-12
- 2026-06-30: Secured Long-term Debt, Noncurrent $42.02M.
- 2026-03-31: Secured Long-term Debt, Noncurrent $87.98M.
- 2025-12-31: Secured Long-term Debt, Noncurrent $103.06M.
- 2025-09-30: Secured Long-term Debt, Noncurrent $15.24M.
| Period end | Secured Long-term Debt, Noncurrent |
|---|---|
| 2026-06-30 | $42.02M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $87.98M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $103.06M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $15.24M 10-Q · filed 2025-11-12 |
| 2024-12-31 | $22.54M 10-K · filed 2026-03-25 |
| 2024-03-31 | $35.37M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $23.67M 10-K · filed 2025-03-21 |
| 2023-09-30 | $22.28M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |